FDA Approvals

Date Posted
Article Title
5/9/2014
Bionic Prosthetic Arm Approved

Helps amputees perform complex tasks by using signals from nearby muscles

5/8/2014
4/21/2014
Cyramza Approved for Stomach Cancer

Disease kills more than 10,000 people annually

4/18/2014
Ragwitek Approved for Adult Ragweed Allergy

Tablet placed under the tongue

4/15/2014
Tanzeum Approved for Type 2 Diabetes

Along with diet and exercise

4/2/2014
Under-the-Tongue Tablet Approved for Grass Allergies

To be started 4 months before allergy season

3/31/2014
Long-Acting Clotting Agent Approved for Form of Hemophilia

Alprolix requires less frequent injections

3/31/2014
Topamax Approval for Migraines Expanded to Younger Users

Adolescents ages 12-17 can now take the drug, FDA says

3/21/2014
Otezla Approved for Psoriatic Arthritis

Condition affects some with psoriasis

3/20/2014
Implanted Hearing Device Approved

For common type of hearing loss

3/20/2014
Impavido Approved to Treat Tropical Parasitic Disease

Americans typically contract it while traveling

3/12/2014
First Device Approved to Prevent Migraines

Headband-like unit stimulates nerve associated with painful headaches

2/25/2014
Myalept Approved for Rare Fat Tissue Disorder

Drug is meant for people with deficiency of the hormone leptin

2/19/2014
Northera Approved For Rare Blood Pressure Condition

Neurogenic orthostatic hypotension is most often tied to Parkinson's disease

2/17/2014
2/12/2014
Imbruvica Approval Expanded to Include Chronic Leukemia

Drug inhibits enzyme that spurs cancer growth

2/4/2014
Blood Sugar Monitoring System Approved for Children

However, device didn't perform as well in kids as in adults, FDA says

1/31/2014
Hetlioz Approved for Sleep Disorder in Blind People

Condition stems from inability to govern sleep from light-dark cycle

1/17/2014
New Test Helps Diagnose Intellectual Disability in Children

Scan tracks entire genome from a blood sample

1/10/2014
Mekinist Plus Tafinlar Approved for Late-Stage Melanoma

The most deadly form of skin cancer